Untreated Follicular Lymphoma

1

Review clinical trials related to Untreated Follicular Lymphoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

This is a global, randomised, Phase III, multicentre, open-label study evaluating the efficacy, safety and the degree of added benefit of the Surovatamig (AZD0486) plus rituximab combination compared to Investigator's choice of 3 standard immunochemotherapy regimen, conducted in participants with untreated FL.

Participants needed: 1,018
Trial details
Phase: Phase 3Age: 18-130Biological sex: AllType: InterventionalSponsor: AstraZenecaUpdated: Aug 19, 2026Locations: 228
Eligibility criteria

Participant must be at least 18 years of age, inclusive, at the time of signing... [+7]

Follicular large B-cell lymphoma (WHO 2022 classification), formerly Follicular... [+6]